Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days

Journal of Digestive Diseases

Volumn 13, Issue 1, 2012, Pages 54-59

  Li, Yuan ^a   Rimbara, Emiko ^a   Thirumurthi, Selvi ^a,b   Trespalacios, Alba ^a   Reddy, Rita ^a   Sabounchi, Saman ^a   Attumi, Taraq Assed ^a   Graham, David Yates ^a  

^a BEN TAUB GENERAL HOSPITAL   (United States)

^b PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

Author keywords

Clarithromycin resistance; Helicobacter pylori; Noncryogenic storage; Polymerase chain reaction; Rapid urease test; Susceptibility test

Indexed keywords

CLARITHROMYCIN; PRIMER DNA; RIBOSOME RNA; UREASE;

ADULT; ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; ERADICATION THERAPY; FEMALE; GENE MUTATION; HELICOBACTER INFECTION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ROOM TEMPERATURE; STOMACH BIOPSY; STORAGE; TISSUE CULTURE; TISSUE SECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOPSY; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; RNA, BACTERIAL; RNA, RIBOSOMAL, 23S; TEMPERATURE; TISSUE PRESERVATION; UREASE;

EID: 84155174831     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2011.00549.x     Document Type: Article

References (21)

1. Graham DY, Sung JY. Helicobacter pylori. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Pathophysiology, Diagnosis, Management. Philadelphia, PA: WB Saunders Co, 2006; 1049-66.
2. Malfertheiner P, Megraud F, O'Morain C etal. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81.
3. Horiki N, Omata F, Uemura M etal. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. Helicobacter 2009; 14: 86-90.
4. Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-84.
5. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010; 59: 1143-53.
6. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997; 41: 2621-8.
7. Versalovic J, Shortridge D, Kibler K etal. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996; 40: 477-80.
8. Alarcon T, Vega AE, Domingo D, Martinez MJ, Lopez-Brea M. Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR- restriction fragment length polymorphism analysis. J Clin Microbiol 2003; 41: 486-99.
9. Schabereiter-Gurtner C, Hirschl AM, Dragosics B etal. Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens. J Clin Microbiol 2004; 42: 4512-8.
10. Trebesius K, Panthel K, Strobel S etal. Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut 2000; 46: 608-14.
11. Xing JZ, Clarke C, Zhu L, Gabos S. Development of a microelectronic chip array for high-throughput genotyping of Helicobacter species and screening for antimicrobial resistance. J Biomol Screen 2005; 10: 235-45.
12. Furuta T, Sagehashi Y, Shirai N etal. Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H. pylori infection. Clin Gastroenterol Hepatol 2005; 3: 564-73.
13. Han SW, Flamm R, Hachem CY etal. Transport and storage of Helicobacter pylori from gastric mucosal biopsies and clinical isolates. Eur J Clin Microbiol Infect Dis 1995; 14: 349-52.
14. Graham DY, Hoffman J, El-Zimaity HM, Graham DP, Osato M. Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1997; 11: 935-8.
15. Kim N, Marcus EA, Wen Y etal. Genes of Helicobacter pylori regulated by attachment to AGS cells. Infect Immun 2004; 72: 2358-68.
16. Ayala G, Chihu L, Perales G etal. Quantitation of H. pylori cytotoxin mRNA by real-time RT-PCR shows a wide expression range that does not correlate with promoter sequences. Microb Pathog 2004; 37: 163-7.
17. Furuta T, Soya Y, Sugimoto M etal. Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin. J Gastroenterol Hepatol 2007; 22: 1810-5.
18. Sugimoto M, Wu JY, Abudayyeh S etal. Caution regarding PCR detection of Helicobacter pylori in clinical or environmental samples. J Clin Microbiol 2009; [epub ahead of print]. DOI: 10.1128/JCM.01563-08.
19. Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S. Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol 1992; 30: 192-200.
20. Fabre R, Sobhani I, Laurent-Puig P etal. Polymerase chain reaction assay for the detection of Helicobacter pylori in gastric biopsy specimens: comparison with culture, rapid urease test, and histopathological tests. Gut 1994; 35: 905-8.
21. de Martel C, Plummer M, van Doorn LJ etal. Comparison of polymerase chain reaction and histopathology for the detection of Helicobacter pylori in gastric biopsies. Int J Cancer 2010; 126: 1992-6.